Standout Papers

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer 2019 2026 2021 2023 1.5k
  1. Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer (2019)
    Fabrice André, Eva Ciruelos et al. New England Journal of Medicine
  2. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease (2020)
    Robert Zeiser, Nikolas von Bubnoff et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 59 standout
Sub-graph 1 of 20

Citing Papers

A vision–language foundation model for precision oncology
2025 StandoutNature
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
1 intermediate paper

Works of Celine Wilke being referenced

Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout

Author Peers

Author Last Decade Papers Cites
Celine Wilke 874 389 745 932 20 2.1k
Ashish M. Ingle 652 374 1212 780 36 2.5k
Scott Cruickshank 1005 575 724 1197 55 2.6k
Leslie B. Lee 975 279 1021 780 13 2.3k
John W. Moroney 431 565 645 850 45 2.4k
Tinya J. Abrams 820 207 921 827 17 2.1k
Susan C. Guba 764 228 658 1288 49 2.3k
Bedia A. Barkoh 603 291 1081 656 45 2.4k
Martina Komor 347 253 578 1580 25 2.5k
Giorgio Massimini 843 309 885 1271 31 2.8k
Kimberly Straley 1302 458 1315 358 24 3.0k

All Works

Loading papers...

Rankless by CCL
2026